Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018135 · ClinicalTrials.gov registry record · NA
Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00018135: Completed NA study, sponsored by National Center for Research Resources (NCRR).
NCT00018135 is a NA study that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00018135, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
Patients on hemodialysis tend to have chronic elevations in the level of phosphorus in the blood and a secondary increase in the iPTH level. This chronic elevation in iPTH can have adverse consequences, thus a variety of phosphate binders are given in an attempt to decrease the absorption of phosphorus present in the normal diet. Some preliminary studies have indicated that the iPTH level may change based on the amount of phosphorus present in a meal prior to any significant absorption of phosphorus. If this is true in hemodialysis patients, then the timing of the administration of phosphate binders in relation to the ingestion of meals needs to be considered
Interventions
- DRUG Sevelamer
- DRUG calcium acetate
- DRUG aluminum hydroxide
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00018135 record still lists
NCT00018135 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which Sevelamer is the first listed.
NCT00018135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00018135 about?
NCT00018135 is a clinical study titled "Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals". Patients on hemodialysis tend to have chronic elevations in the level of phosphorus in the blood and a secondary increase in the iPTH level. This chronic elevation in iPTH can have adverse consequences, thus a variety of phosphate binders are given in an attempt to decrease the absorption of phospho...
What is the current status of trial NCT00018135?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00018135?
The interventions under investigation include: Sevelamer (DRUG), calcium acetate (DRUG), aluminum hydroxide (DRUG).
Who is sponsoring clinical trial NCT00018135?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.